📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected (2011)

First Author: Wason J

Attributed to: Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/0962280211432192

PubMed Identifier: 22179821

Publication URI: http://europepmc.org/abstract/MED/22179821

Type: Journal Article/Review

Parent Publication: Statistical Methods in Medical Research

Issue: 6

ISSN: 0962-2802